BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Psoriasis News and Headlines
Psoriasis News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Psoriasis news alerts.
Site Map > Biotechnology News > Health News > Psoriasis
.

Clinical Trials Update: July 8, 2008
National Womens Health Information Center:  similar ...
Advitech Announces Positive Clinical and Pre-Clinical Results
Pharma Live:  similar ...
Doctor raises awareness with 2,400-mile run: British dermatologist runs Route 66 to educate people of the gene
Therapeutics Daily:  similar ...
Centocor, Inc. submits application to FDA requesting approval of Golimumab for the treatment of Rheumatoid Art
Checkbiotech:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva(R) for the Treatment of Psoriasis
PR Newswire via Yahoo!:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva(R) for the Treatment of Psoriasis
Quote.com Australia:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva(R) for the Treatment of Psoriasis
Macro World Investor:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva(R) for the Treatment of Psoriasis
FinanzNachrichten.de:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva(R) for the Treatment of Psoriasis
Calibre Macro World:  similar ...
EMEA Confirms Positive Benefit-Risk Balance with Raptiva for the Treatment of Psoriasis
Pharma Live:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva for the Treatment of Psoriasis
Therapeutics Daily:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva(R) for the Treatment
FinanzNachrichten.de:  similar ...
EMEA Confirms Positive Benefit-Risk Balance With Raptiva(R) for the Treatment of Psoriasis
Yahoo! Canada:  similar ...
CoPSI comparable to PASI for psoriasis severity assessment
MedWire News:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
San Francisco Business Times:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
The Business Journal Phoenix:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Portland Business Journal:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
San Antonio Business Journal:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Nashville Business Journal:  similar ...
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Art
Atlanta Business Chronicle:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.